These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Calcium hydroxylapatite filler: an overview of safety and tolerability. Pavicic T J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146 [TBL] [Abstract][Full Text] [Related]
44. Identification and Complications of Cosmetic Fillers: Sonography First. Wortsman X J Ultrasound Med; 2015 Jul; 34(7):1163-72. PubMed ID: 26112618 [TBL] [Abstract][Full Text] [Related]
45. Chronic, intractable nodules after filler injection successfully treated with a bipolar radiofrequency device. Hong JY; Suh JH; Ko EJ; Im SI; Kim BJ; Kim MN Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27689829 [No Abstract] [Full Text] [Related]
46. Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapy. Thanasarnaksorn W; Cotofana S; Rudolph C; Kraisak P; Chanasumon N; Suwanchinda A J Cosmet Dermatol; 2018 Oct; 17(5):712-718. PubMed ID: 30006992 [TBL] [Abstract][Full Text] [Related]
47. Adverse effects of fillers and their histopathology. Haneke E Facial Plast Surg; 2014 Dec; 30(6):599-614. PubMed ID: 25536126 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of combination light-emitting diode (635 and 830 nm) therapy in treating local injection-site reactions after filler. Yoo KH; Yeo IK; Hyun MY; Hong CK; Kim BJ Clin Exp Dermatol; 2015 Apr; 40(3):333-5. PubMed ID: 25266806 [No Abstract] [Full Text] [Related]
49. The basic science of dermal fillers: past and present Part II: adverse effects. Gilbert E; Hui A; Meehan S; Waldorf HA J Drugs Dermatol; 2012 Sep; 11(9):1069-77. PubMed ID: 23135649 [TBL] [Abstract][Full Text] [Related]
50. Hyperbaric oxygen therapy for dermal ischemia after dermal filler injection with calcium hydroxylapatite: a case report. Uittenbogaard D; Lansdorp CA; Bauland CG; Boonstra O Undersea Hyperb Med; 2019 Mar-Apr-May; 46(2):207-210. PubMed ID: 31051067 [TBL] [Abstract][Full Text] [Related]
51. Pulsed-dye laser as a novel therapeutic approach for post-filler bruises. Jeong GJ; Kwon HJ; Park KY; Kim BJ Dermatol Ther; 2018 Nov; 31(6):e12721. PubMed ID: 30394647 [TBL] [Abstract][Full Text] [Related]
52. Factitial Panniculitis Associated With Cosmetic Filler. Esquer Garrigos Z; Schuetz AN; Peters MS Mayo Clin Proc; 2019 May; 94(5):914-915. PubMed ID: 31054609 [No Abstract] [Full Text] [Related]
54. Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management. Beer KR J Drugs Dermatol; 2007 Aug; 6(8):846-7. PubMed ID: 17763619 [TBL] [Abstract][Full Text] [Related]
55. How to make calcium hydroxylapatite injections safer. Aguilera SB; Tivoli YA; Seastrom SJ J Drugs Dermatol; 2014 Sep; 13(9):1015. PubMed ID: 25225999 [No Abstract] [Full Text] [Related]
56. The Utility of Color Doppler Ultrasound to Explore Vascular Complications After Filler Injection. Kwon HJ; Kim BJ; Ko EJ; Choi SY Dermatol Surg; 2017 Dec; 43(12):1508-1510. PubMed ID: 28445201 [No Abstract] [Full Text] [Related]
59. Adverse reactions to injectable soft tissue fillers: memorable cases and their clinico-pathological overview. Lee SK; Kim SM; Cho SH; Lee JD; Kim HS J Cosmet Laser Ther; 2015 Apr; 17(2):102-8. PubMed ID: 25260141 [TBL] [Abstract][Full Text] [Related]
60. Alterations in Nasal Sensibility Following Calcium Hydroxyapatite Dorsal Augmentation. Alharethy S J Craniofac Surg; 2018 Mar; 29(2):e104-e106. PubMed ID: 29068971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]